ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery

ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery

Source: 
Fierce Pharma
snippet: 

A combination of Xarelto and aspirin reduced the risk of major limb and cardiovascular events by 15% over aspirin alone in symptomatic peripheral artery disease (PAD) patients who had recently undergone surgery to unblock arteries in their legs, according to data presented Saturday at the American College of Cardiology scientific sessions.